RNAZ Financials

Transcode Therapeutics Inc - Financial statements & key metrics

Stock Price

$2.07

Market Cap

$5.08M

P/E Ratio

-0.0

EPS

$-236.52

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-16.75M

EPS (Diluted)

$-47.14

Balance Sheet Highlights

Total Assets

$7.29M

Total Liabilities

$9.31M

Shareholders Equity

Cash & Equivalents

$5.81M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-13.34M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-1763.0%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is RNAZ revenue?

View RNAZ's income statement for detailed revenue data.

Is RNAZ profitable?

RNAZ reported a loss of $16.75M in the most recent quarter.

What is RNAZ market cap?

RNAZ has a market capitalization of $5.08M, making it a small-cap stock.

Does RNAZ have debt?

View RNAZ's balance sheet for debt information.

What is RNAZ cash flow?

Cash flow data is available in the full financial statements.